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ABSTRACT Previous calculations using crystal structure coordinates (Strickland and
Mercola [1976], Biochemistry. 15: 3857) have predicted that about 40% of the cal-
culated tyrosyl circular dichroism of hexameric insulin is due to one of the four
tyrosine residues: viz. the A14-tyrosine interacting with the nearby Bl-phenylalanine
ring group. We have tested this prediction by measuring the tyrosyl circular dichroism
of an isomorphous analogue of insulin, des-BI-phenylalanine-insulin. Contrary to
expectation, the resulting circular dichroism was the same as that of insulin. It is con-
cluded that the Bl-phenylalanine residue does not in fact make a large contribution
to the circular dichroism of A14-tyrosine. This result is probably due to the thermal
motion of the Bl and A14 ring groups not taken into account by the calculations. An
example of the effects of thermal motion on the calculated circular dichroism is given
and improvements that do take into account thermal motion are discussed.
INTRODUCTION
Theoretical calculations using protein crystal structures have had some success in pre-
dicting the origins of circular dichroism (CD)' of Soret (1, 2) and tyrosyl (3, 4) transi-
tions of several proteins. Hsu and Woody (1) showed that the rotational strength of
the Soret transition of whale myoglobin and horse hemoglobin is due to interactions
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IAbbreviation used in this paper: CD, circular dichroism, difference in extinction of left and right circularly
polarized light, EL - ER, per mole per centimeter of optical path length. The quantity u is a vector as in-
dicated by the boldface type.
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of the heme group with nearby side-chains of aromatic amino acids. The approach was
confirmed by Fleischhauer and Wollmer (2), who correctly predicted the sign inver-
sion of the Soret-Cotton effect observed in Chironomus hemoglobin. Strickland (3),
using the monopole distributions of Woody (5), calculated the tyrosyl CD of ribo-
nuclease, taking into account possible interactions with the chromophores of all
peptide bonds, side chains of histidine, arginine, asparagine, glutamine, aspartic acid,
and glutamic acid, as well as the side chains of aromatic amino acids. Strickland and
Mercola (4) extended this approach to the various aggregation states of insulin. These
calculations predict the correct sign, account for about 70% of the observed CD values,
and predict the fourfold increase in CD that accompanies aggregation of insulin.
These methods are of potential importance for understanding the origins of tyrosyl
CD, for testing structural models, and for interpreting changes in tyrosyl CD when this
group serves as a probe.
As in the case of the heme transitions, the most important sources of tyrosyl CD
are interactions with nearby side chains of aromatic amino acids. For example, in
insulin (4) the calculations suggest that the largest source of tyrosyl CD is the interac-
tion of A14-tyrosine with the ring of BI-phenylalanine that leads to about 40% of the
total calculated tyrosyl CD of the insulin hexamer. This situation can be tested by
examining sequences of insulin with alterations at the A14 or Bl positions. Here we
describe a comparison of the tyrosyl CD of native insulin with an analogue of insulin
that lacks the terminal Bl-phenylalanine residue, des-PheB'-insulin (6). Des-PheBI-
insulin is fully biologically active (6,7), retains normal insulin receptor binding ac-
tivity (8; P. Freychet, personal communication), is immunologically indistinguishable
from insulin (7), exhibits "negative cooperativity" as does insulinj(10),2 has a far-
ultraviolet CD spectrum extremely similar to that of insulin (7), forms rhombohedral
crystals (6, 7) and undergoes the same two-zinc to four-zinc transformation as insulin
(G. Bentley, personal communication). Further X-ray crystal photographs show that
the des-PheBI-insulin crystals are closely isomorphous to native insulin (G. Dodson,
unpublished results). Therefore it seems reasonable to expect that this derivative
would be structurally identical to insulin but would have about 400% reduced tyrosyl
CD owing to the absence of the Bl-phenylalanine contribution. This difference could
not escape observation.
Unexpectedly, the results show that the near-ultraviolet CD of insulin and des-PheBl-
insulin are nearly identical. From this we conclude that the Bl-phenylalanine group
does not in fact contribute to the tyrosyl CD of insulin. The result is discussed in
terms of enhanced thermal motion associated with the A14 and B 1 ring groups, as sug-
gested by the crystal structure refinement results (E. Dodson, G. Dodson, D. C.
Hodgkin, and M. Vijayan, manuscript in preparation). An example of the effects of
2"Negative cooperativity" is a term used to describe the phenomenon in certain bioassays that the affinity
of insulin receptors for insulin is not fixed but decreases as the occupancy of the receptors increases (e.g.
DeMeyts, P., R. A. Bianco, and J. Roth. 1976. J. Biol. Chem. 251: 1877-1888). For examples of the re-
ceptor binding assay see refs. 8- 10.







FIGURE I Illustration of the origin of close contacts between the 14-tyrosyl and BI-phenylala-
nine residues due to intra- and intermolecular contacts. The hexamer of insulin (i.e. two-zinc
insulin) is composed of three dimers related by a threefold axis, A (one complete dimer is shown
here, top, viewed down the threefold crystallographic axis). Each dimer is composed of two
similar molecules, monomers I and II, related by the noncrystallographic twofold axes, OP. As a
consequence of the threefold axis, each dimer is related to adjacent dimers by the noncrystallo-
graphic axes, OQ. The contacts and molecular origin for theA 14 and B I ring groups are shown in
isolation along the bottom OQ axis and in partial isolation for the other two identical OQ axes.
Arrows (bottom) show the position of the Bl-phenyl rings, viewed edge-on here.
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thermal motion on the expected CD values is given and possible improvements to the
calculations that account for the effects of thermal motion are discussed.
METHODS AND MATERIALS
Details of the preparation of des-PheBl-insulin have been described (6). The calculations of
the near-ultraviolet CD of insulin have been described (4) and those for des-PheBi-insulin
were calculated by the same procedures. The total calculated CD for a given aggregation state
(cf. Fig. 1) is the sum of the CD of all tyrosine residues. The contributions to the CD of each
tyrosine residue is calculated for the side chains of all peptide bonds and for the side chains
of all histidine, arginine, glutamate, aspartate, glutamine, asparagine, and phenylalanine
residues, as well as all other tyrosine residues. The calculations are carried out for each
monomer, the dimer, and the hexamer of insulin (Fig. 1). Except where noted, all calculations
are based on the crystal structure of rhombohedral two-zinc insulin refined to an R value of
37.6% (4). The CD measurements described here were made according to methods previously
described (1 1).
RESULTS
The structural organization in crystalline insulin, including the important relationships
between the A 14-tyrosine and Bl-phenyl-alanine ring groups, is illustrated in Fig. 1.
The hexamer of insulin is composed of three identical dimers, each made up of two
similar but not identical monomer structures: monomers I and II. Therefore the cal-
culated (4) contributions of monomers I and II to the tyrosyl CD are different
(Table I). For each of these monomers there are two major sources of calculated CD
for the A14 tyrosyl groups. One source is due to intermolecular contacts, while the
second source is due to intramolecular contacts. Consider intramolecular contacts
first: within each monomer the A14-tyrosyl groups are less than 6 A from their respec-
TABLE I
CALCULATED TYROSYL (275 nm) CIRCULAR DICHROISM (AE, M-I x cm-) FOR
INSULIN AND DES-BI-PHENYLALANINE-INSULIN
Tyr A14/phe Bl,* Bi Insulin with Bl-phenylEnvironment Ring-ring inter- Insulin Des-Phe -insulin
action only group rotation$
Monomer
Monomer I 0.0 -0.39 -0.48 -0.52
Monomer II -1.42 -0.49 +0.93 +0.50
Average -0.71 -0.44 +0.23 -0.01
Dimer No change -2.08 -1.41 -1.64
Hexamer -1.66 -3.36 -1.91 -2.32
AE is given per mole of monomer (6,000). For des-PheB -insulin the absence of the phenyl ring as well as
of the Bl-B2 peptide bond is taken into account.
*Contribution to the BI-phenyl ring only to the AE of tyrosine A14.
tThe contribution of Bl-phenylalanine in the crystallographically defined position was replaced by that
contributed by the B 1 -phenyl group when in constant free rotation about the C#-C,, bond as estimated
by averaging for 10 equal increments of rotation about C#-Cy.
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tive BI-phenyl groups (Fig. 1). For monomer I this proximity does not lead to sig-
nificant CD. However, for monomer II, the A14-tyrosine/B1-phenylalanine interac-
tion leads to a large negative contribution of -1.42 M-' x cm-', about 43% of the
total value calculated for the hexamer. All other interactions leading to CD of the
A 14-tyrosine of monomer II are small and tend to cancel each other.
It is emphasized that these calculations apply to the individual monomers assuming
the structures found in the two-zinc hexamer of insulin. No additional contributions
to the CD of either A 14 tyrosine arise when the monomers are placed in the dimer en-
vironment because both A14 groups are on surfaces of the molecules far from the
region of monomer/monomer contacts (Fig. 1).
The second major source of CD of the A14-tyrosine groups is due to dimer/dimer
contacts in the hexamer (Fig. 1, OQ axis). There are two A14/B1 pairs on the surface
of each dimer and both of these pairs are brought close to an A14/B1 pair of a neigh-
boring dimer by the hexamer symmetry. Therefore in the hexameric state each A 14-
tyrosine is within 6 A of the Bl-phenyl group of the neighboring dimer and within
4 A of the neighboring A 14-tyrosine. For theA14-tyrosine of monomer I the most im-
portant additional contribution arising from hexamer formation is due to the nearby
ring of A14-tyrosine of monomer II (-0.59 M` x cm-'). The contribution from
the BI-phenylalanine of monomer II is small. However, for the A14-tyrosine of
monomer II the contribution from the neighboring B 1-phenylalanine of monomer I is
impressive: - 1.65 M-' x cm-'. This is reinforced by a contribution of -0.4 M` x
cm' due to the A14-tyrosine ofmonomer I.
As a result of all these contributions, the A 14-tyrosyl groups account for about 55%
of the total calculated CD of the hexamer. Clearly the major sources of this calculated
optical activity are interactions (intermolecular) with the Bi-phenyl groups, which
amounts to about 80% of the tyrosyl CD arising from dimer/dimer contacts or over
40% of the total calculated CD of the hexamer.
The expected consequences due to the removal of the BI-phenylalanine residue for
each aggregation state are summarized in Table I. The first column gives the calculated
contribution of the BI-phenyl ring to the CD of the A14-tyrosyl group of each
monomer. These values largely account for the calculated differences between insulin
and des-PheBl-insulin (Table I, column 3 less column 2). For the hexamer, the ex-
pected CD value for des-PheBI-insulin is reduced by more than 40% compared to that
of insulin. For the dimer, the expected CD value for either insulin or des-PheBl-insulin
is smaller due to lost intermolecular contacts, and the differences in CD between insu-
lin and des-PheBl-insulin are also less, about 30%. Similarly the CD values for the
monomers are expected to be further reduced (Table I).
The observed CD values of insulin and des-PheBl-insulin are summarized in Table II.
At the highest concentration studied and in the presence of Zn2+ ions (two atoms of
Zn2+ per six molecules of insulin), insulin is expected to be in a completely hexameric
state (4, 11-13). The observed CD value of -4.22 M' x cm-' for insulin (Table II)
corresponds well with an average of -4.30 M-' x cm-' taken from the literature
(14-16) for similar conditions well known to favor the hexameric form (4,11-13). In
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TABLE II
OBSERVED NEAR-ULTRAVIOLET CIRCULAR DICHROISM (Ae, M-1 x cm-') FOR
INSULIN AND DES-BI-PHENYLALANINE INSULIN
Zinc-free Two zinc atoms per hexamer
Molar concentration
Insulin Des-PheBl-insulin Insulin Des-PheBI-insulin
3.5 x 10-4 -3.12 -3.00 -4.22 -4.22
3.5 x 10-5 -2.68 -2.78 -3.80 -4.06
3.5 x 10-6 -1.87 -2.07 -2.12 -2.84
In all cases Ae given per mole of monomer (6,000) at 275 nm. Insulin and des-PheB'-insulin were mea-
sured in 0.025 M Tris-HCI buffer pH 7.8 with a Cary model 61 CD spectrometer (Varian Associates, Palo
Alto, Calif.) as previously described (11). Values for insulin are taken from Wood et al. (11).
the absence of Zn2+ ions and at progressively lower insulin concentrations, the ob-
served CD values decrease in agreement with the expected dissociation of insulin to
dimers and monomers (4, 11-13). These (Table I) and similar measurements for solu-
tions of insulin in mixed association states have been used in combination with the
association equilibrium constants of Goldman and Carpenter (17) to estimate the
"corrected observed" CD value for the dimers and monomers (4, 11). Corrected CD
values for the dimer in the range of -3.0 to -3.3 M-' x cm-' have been obtained
(4, 11). Thus from the data in Table II it appears that considerable dissociation to
dimers and some monomers has occurred as a result of dilution.
The observed CD values for des-PheBl-insulin measured under identical conditions
as for insulin are also shown in Table II. In striking contrast to the expected 40%/0
reduction in the CD value of the hexameric state, des-Phe51-insulin has the same value
as native insulin, -4.22 M-' x cm-'. In the absence of zinc the observed CD value
of native insulin (-3.12 M-' x cm-') is very similar to the CD values for a popula-
tion of dimeric insulin (4, 11). The observed CD value for des-PheB'-insulin,
-3.00 M-' x cm-', under the same conditions is also very nearly identical to that
of insulin. Similarly, at lower concentrations in the absence of zinc, the CD intensi-
ties of both des-PheBI-insulin and insulin decrease to similar values. In fact at the
lowest concentration in the presence of zinc, the CD intensity of des-Phe51-insulin is
rather larger than that of insulin. Therefore it is apparent from these comparisons
that the removal of the B1-phenylalanine residue does not lead to a decrease in the
tyrosyl CD intensity of insulin.
DISCUSSION
In general there are two possible reasons for this discrepancy between theory and
experiment. The crystal structure model used for the calculations may somehow be
inappropriate and/or there may be an inadequacy in the method of calculation. It
seems unlikely that the crystal structure is inappropriate due to differences in the struc-
ture of insulin in the crystalline and aqueous phases. A large amount of evidence
from physical, chemical, biological, and immunochemical studies has been accumu-
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lated about the structure in solution and has been reviewed recently (12, 13). From
this it is reasonably certain that the zinc-containing hexamer of insulin in solution is
essentially the same as that in rhombohedral crystals (18). Less is known about the
structure of monomers and dimers of insulin in solution, though the weight of evi-
dence favors similarity (12,13). For example, the distance between spectroscopic
probes covalently bound to terminal residues of the monomer in solution are in agree-
ment with the crystal structure (19). In addition the asymmetry in the dimer in
rhombohedral crystals has also been observed in solution (20).
Similar questions arise when considering the structure of des-PheBl-insulin, i.e. is
the structure of des-Phe'l-insulin, especially with respect to the A 14-tyrosine, identical
to that of insulin apart from the missing terminal residue? Des-Phe8'-insulin is
probably the most extensively characterized chemical modification of insulin known.
All reported biological, immunological, and physical properties are very similar if not
identical to that of insulin (6-1 1), suggesting very similar or identical structures. Sev-
eral observations from the crystal structure analysis support this conclusion. An inde-
pendent structure determination of a second form of rhombohedral insulin, four-zinc
insulin, has recently been described (21). A hexamer is also present but the NH2-
terminal B-chain (B1 Phe to B8 Gly) of one monomer in each dimer (monomer I)
has undergone an extended chain-to-helix transition so that the close contacts between
the B1-I phenyl group and the pair ofA 14 phenolic groups (cf. Fig. 1) are lost and the
separation is now 25 A. As a result, the neighboring Bi-lI phenylalanine residue is
also somewhat rearranged, leading to an increased separation of over 10 A from the
A14 phenolic pair. However, in spite of these large motions, the positions of the A14
tyrosine residues are very nearly unchanged. This is likely due to an intermolecular
hydrogen bond between the hydroxyl functions of the phenolic groups and other
close dimer/dimer contacts. These observations show that the position of the A14
phenolic groups in the hexamer are not dependent on the Bi residues and that the
absence of these phenyl groups does not necessarily lead to changes at the A14 resi-
dues. The examination of crystalline des-PheBl-insulin also supports this view. Des-
PheBI-insulin crystallizes in the same space group as insulin, and X-ray photographs to
a resolution of 2.15 A spacing show that insulin and des-PheBI-insulin are closely
isomorphous. These observations suggest that it is reasonable to assume that the two-
zinc crystal structure of insulin is a valid model for des-PheBl-insulin. In addition, the
crystal structure has proved useful in predicting the effects of aggregation on the ob-
served CD. For these reasons and the above, it is assumed in what follows that the
crystal coordinates are a valid model for insulin and des-PheBl-insulin (see Methods
and Materials).
Alternatively it is possible to identify a limitation in the calculations. The method of
calculation predicts the total tyrosyl CD intensity as a function of a point monopole
distribution. The fixed nature of the monopoles is due to the use of point atoms fixed
by the crystal structure coordinates. This approach leads to calculations of tyrosyl
CD at 0°K. Therefore comparison of calculated values to observations made at ele-
vated temperatures may require special precautions. For example, the effects of
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thermal excitation may cause the temperature dependence of tyrosyl CD, as observed
for some proteins over the range of 77-298°K. For ribonuclease S and ribonuclease A
the CD intensity decreases upon increasing the temperature from 77°K to 298°K (22),
whereas the CD intensity of tropomyosin (J. Horwitz and B. Bullard, personal com-
munication) is nearly independent of temperature over this range. Preliminary studies
of insulin suggest that some increase in CD does occur upon cooling to 77°K (E. H.
Strickland, personal communication; H. Schnitz, personal communication).
Where there is a temperature dependence of the tyrosyl CD, if the effects of thermal
excitation were equal and isotropic for all atoms, it might be expected that all calcu-
lated and observed contributions to the CD intensity would be related by a simple
multiplicative factor. However, for proteins it is well known from crystal structure
studies at ambient temperatures that surface residues are less well stabilized than
internal residues. Therefore it may be anticipated that surface ring groups may be
particularly susceptible to thermal excitation. Recent nuclear magnetic resonance
studies of proteins in solution at ambient temperature indeed suggest that this is the
case. Some of the ring groups of the tyrosyl and phenylalanine residues in lyso-
zyme (22), bacterial ferredoxin (23), pancreatic trypsin inhibitor (24,25), horse ferni-
cytochrome c (26), parvalbumin (27), and troponin-C (28) have been shown to ro-
tate (22,25,26) or flip (22,26) with frequencies of 104 s-'. A second class of ring
groups in these proteins is not involved in such averaging motions. The two classes of
ring groups are attributed to differences in the thermal stability of surface and internal
residues (22,23,25-26).
In the case of insulin, surface ring groups such as the A14-tyrosine and BI-phenyl-
alanine residues are likely candidates for such motions in solution. As an illustration,
we have calculated the effects of rotation on the total calculated CD intensity by as-
suming free rotation of the Bl-phenylalanine ring group about the C,6-C, bond, and
the results are given in Table I. When rotation of the B 1-phenyl ring is included, the
CD values of insulin calculated for each association state are reduced and much
closer to those calculated for des-PheBl'-insulin. This result suggests that the A14/B1
pair may not generate as much CD as has been calculated for native insulin if rotation
occurs for one or both of these ring groups, and that then the decrease expected for
des-PheB1-insulin would have been overestimated. In general the reduction in CD is
not surprising. Although incremental rotations may lead to some positions with
large CD contributions, when averaged over a complete rotation, positive and negative
contributions would tend to cancel. A similar effect then may be expected for the
A 14-tyrosine residue. In agreement with these conclusions, the current work on the
crystallographic refinement of the rhombohedral crystal structure suggests that these
two ring groups do have above average thermal parameters (E. Dodson, G. Dodson,
D. C. Hodgkin, M. Vijayan; manuscript in preparation).
The illustration using rotation, one plausible mode of thermal motion, is a particular
example and so does not provide a general basis for correcting the calculated CD
values. However, in crystal structure refinement the thermal properties of atoms can
be determined and are most easily described in terms of the temperature factor B (30).
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For proteins, thermal motion may be approximated by isotropic B values related to
the rms displacement, u, due to vibration or other modes by B = 8ir2u2 (30). Thus
the B values are time-averaged descriptions of atomic motion. For internal residues
of proteins these values are commonly in the range 5-15 A2, whereas for surface
groups these values may be considerably higher. The recent crystallographic refine-
ment results for insulin show that the average atomic B values for the ring group of the
A14-tyrosine and Bl-phenylalanine are about 25 A2 and 35 A2, respectively, i.e.
somewhat elevated. The possible consequences of these values for the calculated
tyrosyl CD intensity may be seen by noting that, for isotropic B values, atomic dis-
placements are equal in all directions and u = 0. Then the standard deviation of
u, (u), is simply K/u2 = B The standard deviation, in turn, defines the
spread or width of a normal distribution of displacement about a mean position for a
vibrating atom or any other quantity rigidly fixed to the atom such as a monopole.
The important quantity for calculation of the CD influenced by these considerations
is the interaction potential between any two monopoles (1, 3). For large B values and
small monopole separations the normal distribution function may show that the two
monopole distributions overlap. It is clear from simple electrostatics that in the case
of overlapping charge distributions the calculated potential and resulting CD will be
decreased. For ease of discussion here we define an equivalent radius, re, of a vibrat-
ing monopole as the radius of a sphere containing over 99.7% of the monopole
charge, i.e. re = 3- a(u). Then two monopoles whose 2:re is less than their center-to-
center separation (as defined by the crystal structure) will not overlap and will have
an interaction potential and CD equal to that of point atoms. For example, for two
average monopoles with B -10 A2, overlap does not occur for separations over
2.0 A. Separations of more than 2.0A are in fact the case for over 90% of all
the important monopole interactions calculated for insulin (4). Therefore calculations
with average or well-ordered atoms at 298°K are likely to lead to a similar result
as that for 0°K. However, if one or both of the interacting groups are disordered, say
B, = 35 AX and B2 = 25 A2, (as might be expected for the BI and A14 ring atoms),
then Zr, is 3.8 A or considerably larger than, for example, the average minimum
separation of monopoles in any of the four A14/B1 pairs in insulin, -mm 2.0 A.
Therefore in this case an overlap in some of the monopole pairs and a reduction of the
interaction potential must be expected. Thus the preliminary vibrational parameters
of crystalline insulin, as studied at ambient temperature, predict that the observed
CD of the A14-tyrosine/Bl-phenylalanine interactions may be less than that cal-
culated at 0°K. This is consistent with the model calculation, where the Bl-phenyl
group was allowed to rotate freely. These considerations, then, provide a qualitative
explanation why removal of Bl-phenylalanine had no effect on the tyrosyl CD of
insulin.
The line of reasoning developed here suggests several possible ways to quantitatively
calculate the tyrosyl CD of proteins at ambient temperature. In the simplest case each
fixed monopole would be replaced by a Gaussian charge distribution centered at the
monopole coordinate with an integrated volume equal to that of the monopole and
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with standard error of B7P. In this way monopoles with large B values become
symmetrically "smeared" in space due to thermal excitation while monopoles with
small B values approximate point monopoles as before. There are several other pos-
sible advantages in this approach. For one, B values represent the observed effects
of all disordering influences for each atom (or monopoles) and so are independent
of any particular model, such as partial or free rotation, vibration, or other modes.
For another, the use of a Gaussian distribution of positions means that all "allowed"
local variations in the structure, which considered separately may produce significantly
differing SE values, may now all enter into the calculations weighted by their probabili-
ties of occurrence. Previous results have in fact shown that small changes in the co-
ordinates led to significantly different Ac values even though the total CD was not
much affected by the changes (4). The methods discussed here may minimize this sensi-
tivity, and small changes in the coordinates during the refinement process will not
necessarily lead to large changes in AE values. However, it remains to be shown that
this treatment when combined with the final crystallographic coordinates and B values
will lead to a quantitative explanation of the results observed with des-Phe'3-insulin.
These studies are in progress.
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